What Are ADCs And How Do They Work Against Cancer?
Source: NanoTemper Technologies, Inc.
Antibody-drug conjugates (ADCs) are a promising avenue for precision cancer treatments. What makes them so interesting, is their ability to combine the targeting power of a monoclonal antibody, with the druggability of a small molecule.
In this short animated video, learn the basics of how ADCs are engineered and why that makes them such powerful tools to target cancers with precision.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
NanoTemper Technologies, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more